180 related articles for article (PubMed ID: 26404758)
1. Radiopharmacology: recent developments in the field of radiopharmaceuticals.
Cutler CS
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):239-40. PubMed ID: 26404758
[No Abstract] [Full Text] [Related]
2. What nuclear cardiology can learn from nuclear oncology.
Sarikaya I; Larson SM; Freiman A; Strauss HW
J Nucl Cardiol; 2003; 10(3):324-8. PubMed ID: 12794632
[No Abstract] [Full Text] [Related]
3. 2017 SNMMI Highlights Lecture: Oncology.
Weber W
J Nucl Med; 2018 Jan; 59(1):7N-13N. PubMed ID: 29295949
[No Abstract] [Full Text] [Related]
4. 2015 SNMMI Highlights Lecture: Oncology, Part II.
Mahmood U
J Nucl Med; 2015 Dec; 56(12):9N-16N. PubMed ID: 26626870
[No Abstract] [Full Text] [Related]
5. Diagnostic imaging in oncology. Proceedings of a meeting. Naples, Italy, 28-30 April 1993.
Nucl Med Biol; 1994 Jul; 21(5):681-792. PubMed ID: 9289312
[No Abstract] [Full Text] [Related]
6. Personalized medicine in oncology, the potential role of nuclear medicine imaging.
Van de Wiele C; Mees G
Curr Pharm Des; 2014; 20(14):2231-3. PubMed ID: 24025097
[No Abstract] [Full Text] [Related]
7. 2015 SNMMI Highlights Lecture: Oncology, Part I.
Mahmood U
J Nucl Med; 2015 Nov; 56(11):9N-16N. PubMed ID: 26526798
[No Abstract] [Full Text] [Related]
8. New aspects of molecular imaging in prostate cancer.
Ceci F; Castellucci P; Cerci JJ; Fanti S
Methods; 2017 Nov; 130():36-41. PubMed ID: 28711565
[TBL] [Abstract][Full Text] [Related]
9. SNMMI 2015 Image of the Year.
J Nucl Med; 2015 Aug; 56(8):9N. PubMed ID: 26240085
[No Abstract] [Full Text] [Related]
10. A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.
Verburg FA; Luster M
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1611-1613. PubMed ID: 28677048
[No Abstract] [Full Text] [Related]
11. Imaging of Prostate Cancer Using
Singh A; Kulkarni HR; Baum RP
PET Clin; 2017 Apr; 12(2):193-203. PubMed ID: 28267453
[TBL] [Abstract][Full Text] [Related]
12. [Nuclear oncology 2000: the end of individualized professionalism].
Carrio I
Rev Esp Med Nucl; 2000 Jun; 19(3):179-81. PubMed ID: 11062079
[No Abstract] [Full Text] [Related]
13. Introduction of nuclear medicine research in Japan.
Inubushi M; Higashi T; Kuji I; Sakamoto S; Tashiro M; Momose M
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2449-2452. PubMed ID: 27492625
[TBL] [Abstract][Full Text] [Related]
14. Nuclear oncology and the Imagene concept.
Urbain JL; Vekemans MC; Lemieux SK; Cosenza SC; Senadhi VK; Milestone BN; Reddy EP
Acta Radiol Suppl; 1997; 412():21-8. PubMed ID: 9240077
[TBL] [Abstract][Full Text] [Related]
15. Pursuit of the ideal perfusion agent.
Zaret BL
J Nucl Cardiol; 2002; 9(2):149-50. PubMed ID: 11986557
[No Abstract] [Full Text] [Related]
16. PET/CT with sodium 18F-fluoride for management of patients with prostate cancer.
Segall GM
J Nucl Med; 2014 Apr; 55(4):531-3. PubMed ID: 24591486
[No Abstract] [Full Text] [Related]
17. Special issue: Nuclear oncology.
J Nucl Med; 1996 Jun; 37(6):885-1063. PubMed ID: 8683304
[No Abstract] [Full Text] [Related]
18. Highlights of the 2009 Scientific Session of the American Society of Nuclear Cardiology: Minneapolis, Minnesota, October 1-4, 2009.
Russell RR; Abbott BG; Arrighi JA; Blankstein R; Cohen MC; Faber TL; Mieres JH; Miller TD; Tilkemeier PL; Travin MI; Bax JJ
J Nucl Cardiol; 2010; 17(1):97-105. PubMed ID: 19960288
[No Abstract] [Full Text] [Related]
19. Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA.
Psimadas D; Valotassiou V; Alexiou S; Tsougos I; Georgoulias P
Cancer Invest; 2018 Feb; 36(2):118-128. PubMed ID: 29393702
[TBL] [Abstract][Full Text] [Related]
20. [¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.
Kratochwil C; Giesel FL; Eder M; Afshar-Oromieh A; Benešová M; Mier W; Kopka K; Haberkorn U
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):987-8. PubMed ID: 25573634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
